IMNM Stock Analysis: Buy, Sell, or Hold?
IMNM - Immunome, Inc.
$19.33
0.15 (0.78%)
▲
5d:
+6.97%
30d:
-15.81%
90d:
-6.84%
BUY
MODERATE Confidence
Analysis Updated: Jun 23, 2026 12:00 AM ET
Earnings: Aug 05, 2026
Get Alerted When IMNM Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
💡 BUY OPPORTUNITY: IMNM shows positive signals but monitor for confirmation. Company currently unprofitable (negative forward earnings). Moderate conviction.
💡 BUY OPPORTUNITY: IMNM shows positive signals but monitor for confirmation. Company currently unprofitable (negative forward earnings). Moderate conviction.
In-depth Analysis How we analyze
Valuation Analysis: IMNM is currently trading at $19.33, which is considered fair relative to its 30-day fair value range of $18.34 to $21.42.
Technical Outlook: Technically, IMNM is in a downtrend. The price is approaching resistance at $19.66. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: The stock shows a mixed technical setup (45/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $35.77 (+85.0%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, IMNM is in a downtrend. The price is approaching resistance at $19.66. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: The stock shows a mixed technical setup (45/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $35.77 (+85.0%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
FAIR
Historical Trading Range
$18.34 -
$21.42
Company Quality Score
61/100
(BUY)
Volume Confirmation
HIGH
Confidence Score
74.7%
All Signals
- NEUTRAL: Price in fair range
- NEUTRAL: Mixed technical signals (45/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 85.0% below Wall St target ($35.77)
Trading Range Analysis
30-Day Trading Range
$18.34 -
$21.42
Current vs Trading Range
FAIR
Support & Resistance Levels
Support Level
$17.83
Resistance Level
$19.67
Current Trend
Downtrend
Technical data as of
Jun 23, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-9.22
Wall Street Target
$35.77
(+85.0%)
Revenue Growth (YoY)
-100.0%
Share & Embed Analysis
Last updated: June 24, 2026 8:05 AM ET
Data refreshes hourly during market hours. Next update: 9:05 AM
Data refreshes hourly during market hours. Next update: 9:05 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is IMNM showing a specific setup today?
Insider Activity (6 Months)
2
Buys
4
Sells
Net
INSIDERS SELLING
Recent Transactions
Jack Higgins
SELL
9438 shares
2026-04-02
Max Rosett
SELL
65000 shares
2026-04-02
Philip Wagenheim
SELL
28200 shares
2026-03-23
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
SRPT
Sarepta Therapeutics Inc |
STRONG BUY
26 analysts |
$22 | 54 HOLD |
|
NRIX
Nurix Therapeutics Inc |
STRONG BUY
18 analysts |
$31 | 62 BUY |
|
BNTX
BioNTech SE |
STRONG BUY
21 analysts |
$122 | 55 HOLD |
|
DYN
Dyne Therapeutics Inc |
STRONG BUY
14 analysts |
$38 | 62 BUY |
|
DNTH
Dianthus Therapeutics In… |
STRONG BUY
12 analysts |
$128 | 57 HOLD |
Advanced IMNM Option Strategies
Professional options setups generated by AI based on today's IMNM price and gamma walls.
